Preventing bone loss and weight gain with combinations of vitamin d and phytochemicals

Journal of Medicinal Food

Volumn 14, Issue 11, 2011, Pages 1352-1362

  Lai, Ching Yi ^a   Yang, Jeong Yeh ^b   Rayalam, Srujana ^b   Della Fera, Mary Anne ^b   Ambati, Suresh ^b   Lewis, Richard D ^a   Hamrick, Mark W ^c   Hartzell, Diane L ^b   Baile, Clifton A ^a,b  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

bone loss; genistein; osteoporosis; ovariectomized rats; quercetin; resveratrol

Indexed keywords

GENISTEIN; QUERCETIN; RESVERATROL; SOMATOMEDIN C; VITAMIN D;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE MASS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG MEGADOSE; FEMALE; FEMUR; FOOD INTAKE; LOW DRUG DOSE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; NONHUMAN; OBESITY; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TRABECULAR BONE; WEIGHT GAIN;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; DIET; DIETARY SUPPLEMENTS; DRUG COMBINATIONS; FEMALE; FEMUR; GENISTEIN; OVARIECTOMY; PHYTOTHERAPY; QUERCETIN; RATS; RATS, INBRED F344; STILBENES; VITAMIN D; WEIGHT GAIN;

RATTUS;

EID: 80755175258     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2010.0232     Document Type: Article

References (54)

1. National Institutes of Health: Osteoporosis and Related Bone Diseases National Resource Center Fact Sheets. www.niams .nih.gov/Health-Info/Bone/ Osteoporosis/default.asp (accessed August 2008).
2. National Osteoporosis Fundation: Fast Facts on Osteoporosis. http://nof.org/osteoporosis/diseasefacts.htm (accessed August 2008).
3. Bone Health and Osteoporosis: A Report of the Surgeon General. U.S. Department of Health and Human Services, Washington, DC, 2004.
4. Meunier P, Aaron J, Edouard C, Vignon G: Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 1971;80:147-154.
5. Verma S, Rajaratnam JH, Denton J, Hoyland JA, Byers RJ: Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol 2002;55:693-698. (Pubitemid 34970093)
6. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M: Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2001;2:165-171. (Pubitemid 32851325)
7. Setchell KDR, Lydeking-Olsen E: Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 2003;78(3 Suppl)593S-609S. (Pubitemid 40012554)
8. McCarty MF: Isoflavones made simple-genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. Med Hypotheses 2006;66:1093-1114.
9. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F: Effects of genistein and hormonereplacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 2002;17:1904-1912.
10. Kim HK, Nelson-Dooley C, Della-Fera MA, Yang JY, Zhang W, Duan J, Hartzell DL, Hamrick MW, Baile CA: Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice. J Nutr 2006;136:409-414. (Pubitemid 43228294)
11. Price KR, Rhodes MJC: Analysis of the major flavonol glycosides present in four varieties of onion (Allium cepa) and changes in composition resulting from autolysis. J Sci Food Agric 1997;74:331-339. (Pubitemid 27288768)
12. Muhlbauer RC, Li F: Effect of vegetables on bone metabolism. Nature 1999;401:343-344.
13. Wattel A, Kamel S, Mentaverri R, Lorget F, Prouillet C, Petit JP, Fardelonne P, Brazier M: Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem Pharmacol 2003;65:35-42. (Pubitemid 35447836)
14. Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, Brazier M: Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J Cell Biochem 2004;92:285-295.
15. Woo JT, Nakagawa H, Notoya M, Yonezawa T, Udagawa N, Lee IS, Ohnishi M, Hagiwara H, Nagai K: Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts. Biol Pharm Bull 2004;27:504-509. (Pubitemid 41701834)
16. Rassi CM, Lieberherr M, Chaumaz G, Pointillart A, Cournot G: Modulation of osteoclastogenesis in porcine bone marrow cultures by quercetin and rutin. Cell Tissue Res 2005;319:383-393. (Pubitemid 40379408)
17. Hausman DB, Della-Fera MA, Hartzell DL, Yang JY, Park HJ, Hamrick MW, Baile CA: Quercetin, a bioflavonol, inhibits adipogenesis and stimulates osteogenesis in mesenchymal stem cells from human bone marrow (hMSC). J Bone Miner Res 2006;21:S256.
18. Kim YJ, Bae YC, Suh KT, Jung JS: Quercetin, a flavonoid, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells. Biochem Pharmacol 2006;72:1268-1278. (Pubitemid 44572193)
19. Horcajada-Molteni MN, Crespy V, Coxam V, Davicco MJ, Remesy C, Barlet JP: Rutin inhibits ovariectomy-induced osteopenia in rats. J Bone Miner Res 2000;15:2251-2258.
20. Tsuji M, Yamamoto H, Sato T, Mizuha Y, Kawai Y, Taketani Y, Kato S, Terao J, Inakuma T, Takeda E: Dietary quercetin inhibits bone loss without effect on the uterus in ovariectomized mice. J Bone Miner Metab 2009;27:673-681.
21. Strobel P, Allard C, Perez-Acle T, Calderon R, Aldunate R, Leighton F: Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem J 2005; 386:471-478. (Pubitemid 40445871)
22. Kuppusamy UR, Das NP: Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. Biochem Pharmacol 1992;44:1307-1315.
23. Rivera L, Moron R, Sanchez M, Zarzuelo A, Galisteo M: Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 2008;16:2081-2087.
24. Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T, Delaisse JM: Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoclast differentiation. Cancer Res 2005;65:9943-9952. (Pubitemid 41541475)
25. Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, Napper A, Curtis R, DiStefano PS, Fields S, Bedalov A, Kennedy BK: Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 2005;280:17038-17045. (Pubitemid 41389166)
26. Harikumar KB, Aggarwal BB: Resveratrol-a multitargeted agent for age-associated chronic diseases. Cell Cycle 2008;7: 1020-1035.
27. Guarente L, Picard F: Calorie restriction-the SIR2 connection. Cell 2005;120:473-482.
28. Mizutani K, Ikeda K, Kawai Y, Yamori Y: Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 1998;253:859-863. (Pubitemid 29039235)
29. Liu ZP, Li WX, Yu B, Huang J, Sun J, Huo JS, Liu CX: Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model. J Med Food 2005;8:14-19. (Pubitemid 40617031)
30. Kong J, Li YC: Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 2006;290:E916-E924.
31. Sun XC, Zemel MB: Role of uncoupling protein 2 (UCP2) expression and 1alpha,25-dihydroxyvitamin D-3 in modulating adipocyte apoptosis. FASEB J 2004;18:1430-1432. (Pubitemid 39561604)
32. Yoshikawa T, Peel SAF, Gladstone JR, Davies JE: Biochemical analysis of the response in rat bone marrow cell cultures to mechanical stimulation. Biomed Mater Eng 1997;7:369-377. (Pubitemid 127719814)
33. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH: Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295. (Pubitemid 35471185)
34. Arunabh S, Pollack S, Yeh J, Aloia JF: Body fat content and 25- hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 2003;88:157-161. (Pubitemid 36115158)
35. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, Yanovski JA: The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004;89:1196-1199. (Pubitemid 38368412)
36. Rayalam S, Della-Fera MA, Ambati S, Yang JY, Park HJ, Baile CA: Enhanced effects of 1,25(OH)2D3 plus genistein on adipogenesis and apoptosis in 3T3-L1 adipocytes. Obesity (Silver Spring) 2008;16:539-546. (Pubitemid 351328003)
37. Park HJ, Yang JY, Ambati S, Della-Fera MA, Hausman D, Rayalam S, Baile CA: Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes. J Med Food 2008;11:773-783.
38. Rayalam S, Della-Fera MA, Yang JY, Park HJ, Ambati S, Baile CA: Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. J Nutr 2007;137: 2668-2673. (Pubitemid 350255295)
39. Rayalam S, Yang JY, Ambati S, Della-Fera MA, Baile CA: Resveratrol induces apoptosis and inhibits adipogenesis in 3T3- L1 adipocytes. Phytother Res 2008; 22:1367-1371.
40. Yang JY, Della-Fera MA, Rayalam S, Ambati S, Hartzell DL, Park HJ, Baile CA: Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci 2008;82:1032-1039.
41. Kato Y, Shimazu A, Iwamoto M, Nakashima K, Koike T, Suzuki F, Nishii Y, Sato K: Role of 1,25-dihydroxycholecalciferol in growth-plate cartilage: inhibition of terminal differentiation of chondrocytes in vitro and in vivo. Proc Natl Acad Sci U S A 1990;87:6522-6526.
42. Pedulla M, Desiderio V, Graziano A, d'Aquino R, Puca A, Papaccio G: Effects of a vitamin D3 analog on diabetes in the Bio Breeding (BB) rat. J Cell Biochem 2007;100:808-814. (Pubitemid 46180541)
43. Naaz A, Yellayi S, Zakroczymski MA, Bunick D, Doerge DR, Lubahn DB, Helferich WG, Cooke PS: The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 2003;144:3315-3320. (Pubitemid 36904405)
44. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J: Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006;127:1109-1122. (Pubitemid 44894520)
45. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA: Resveratrol improves health and survival of mice on a highcalorie diet. Nature 2006;444:337-342. (Pubitemid 44764104)
46. Kandulska K, Nogowski L, Szkudelski T: Effect of some phytoestrogens on metabolism of rat adipocytes. Reprod Nutr Dev 1999;39:497-501. (Pubitemid 30095350)
47. Szkudelska K, Nogowski L, Szkudelski T: Genistein affects lipogenesis and lipolysis in isolated rat adipocytes. J Steroid Biochem Mol Biol 2000;75:265-271. (Pubitemid 32244256)
48. Szkudelska K, Nogowski L, Szkudelski T: Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes. J Steroid Biochem Mol Biol 2009;113:17-24.
49. Arjmandi BH, Khalil DA, Smith BJ, Lucas EA, Juma S, Payton ME, Wild RA: Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 2003;88:1048-1054. (Pubitemid 36337755)
50. Songlin P, Ge Z, Yixin H, Xinluan W, Pingchung L, Kwoksui L, Ling Q: Epimedium-derived flavonoids promote osteoblastogenesis and suppress adipogenesis in bone marrow stromal cells while exerting an anabolic effect on osteoporotic bone. Bone 2009;45:534-544.
51. Rao A, Woodruff RD, Wade WN, Kute TE, Cramer SD: Genistein and vitamin D synergistically inhibit human prostatic epithelial cell growth. J Nutr 2002;132:3191-3194.
52. Wietzke JA, Welsh J: Phytoestrogen regulation of a vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells. J Steroid Biochem Mol Biol 2003;84:149-157. (Pubitemid 36514832)
53. Marini H, Bitto A, Altavilla D, Burnett BP, Polito F, Di Stefano V, Minutoli L, Atteritano M, Levy RM, D'Anna R, Frisina N, Mazzaferro S, Cancellieri F, Cannata ML, Corrado F, Frisina A, Adamo V, Lubrano C, Sansotta C, Marini R, Adamo EB, Squadrito F: Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. J Clin Endocrinol Metab 2008;93:4787-4796.
54. Michael McClain R, Wolz E, Davidovich A, Pfannkuch F, Edwards JA, Bausch J: Acute, subchronic and chronic safety studies with genistein in rats. Food Chem Toxicol 2006;44:56-80. (Pubitemid 41773804)